Accord Logo

Intended for UK patients and members of the public

Gabapentin Tablets

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Gabapentin Accord 600 mg Film-coated Tablets

PL Number:
20075/0302
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • To update SmPC sections 4.4, 4.6, 4.8, 4.9, 5.1 and PIL section in line with the reference product Neurontin 600 mg film-coated tablets (EU procedure number: DE/H/0899/004, MAH: Upjohn EESV, Ref Revision date: 03/2024).

  • The following changes have been notified:  

    • Type IAIN - B.II.b.1.a - addition of a manufacturing site for part or all of the manufacturing process of the finished product - secondary packaging site - addition of Accord Healthcare Single Member S.A., Greece as a secondary packaging site.

    • Type IAIN - B.II.b.2.c.2 - change to batch release arrangements and quality control testing of the finished product - addition of a manufacturer responsible for importation and/or batch release - including batch control/testing - addition of Accord Healthcare Single Member S.A., Greece as a site responsible for batch certification and chemical/physical & microbiological non-sterility quality control testing.

    The manufacturers in Section 6 of the PIL have been updated.

    PIL sections updated: Section 6 only.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Gabapentin Accord 800 mg Film-coated Tablets

PL Number:
20075/0303
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • To update SmPC sections 4.4, 4.6, 4.8, 4.9, 5.1 and PIL section in line with the reference product Neurontin 600 mg film-coated tablets (EU procedure number: DE/H/0899/004, MAH: Upjohn EESV, Ref Revision date: 03/2024).

  • The following changes have been notified:  

    • Type IAIN - B.II.b.1.a - addition of a manufacturing site for part or all of the manufacturing process of the finished product - secondary packaging site - addition of Accord Healthcare Single Member S.A., Greece as a secondary packaging site.

    • Type IAIN - B.II.b.2.c.2 - change to batch release arrangements and quality control testing of the finished product - addition of a manufacturer responsible for importation and/or batch release - including batch control/testing - addition of Accord Healthcare Single Member S.A., Greece as a site responsible for batch certification and chemical/physical & microbiological non-sterility quality control testing.

    The manufacturers in Section 6 of the PIL have been updated.

    PIL sections updated: Section 6 only.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: